PDF (2,8 MB) - Ãrad priemyselného vlastnÃctva SR
PDF (2,8 MB) - Ãrad priemyselného vlastnÃctva SR
PDF (2,8 MB) - Ãrad priemyselného vlastnÃctva SR
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
VESTNÍK ÚRADU PRIEMYSELNÉHO VLASTNÍCTVA <strong>SR</strong> 6 - 2010 - SK (preklady patentov) 37<br />
(73) Bristol-Myers Squibb Company, Princeton, NJ, US;<br />
(72) CHEN Bang-Chi, Plainsboro, NJ, US; DROG-<br />
HINI Roberto, Candiac, Quebec, CA; LAJEU-<br />
NESSE Jean, Candiac, Quebec, CA; DIMARCO<br />
John D., East Brunswick, NJ, US; GALELLA<br />
Michael, Kendall Park, NJ, US; CHIDA<strong>MB</strong>A-<br />
RAM Ramakrishnan, Pennington, NJ, US;<br />
(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />
SK;<br />
(86) PCT/US2005/003728<br />
(87) WO 2005/077945<br />
(54) Spôsob prípravy 2-aminotiazol-5-aromatických<br />
karboxamidov ako inhibítorov kinázy<br />
(51) C07D 333/00<br />
(11) E 6924<br />
(96) 07004341.9, 2.3.2007<br />
(97) 1964838, 30.12.2009<br />
(24) 30.12.2009<br />
(73) EDMOND PHARMA S.R.L., Milano, IT;<br />
(72) Nicola Massimo, Pavia, IT; Gatti Pier Andrea, San<br />
Genesio ed Uniti, IT; Zacche Matteo, Vanzago, IT;<br />
(74) Fajnorová Mária, Ing., Bratislava, SK;<br />
(54) Spôsob rozdelenia homocysteín-tiolaktónu<br />
(51) C07D 401/00, A61K 31/473, A61P 11/00<br />
(11) E 6840<br />
(96) 06708593.6, 1.3.2006<br />
(97) 1856093, 2.12.2009<br />
(24) 2.12.2009<br />
(31) 05101619, 05108442<br />
(32) 2.3.2005, 14.9.2005<br />
(33) EP, EP<br />
(73) Nycomed GmbH, Konstanz, DE;<br />
(72) KAUTZ Ulrich, Allensbach, DE; WEBEL Matthias,<br />
Radolfzell, DE; SCHEUFLER Christian,<br />
Engen-Neuhausen, DE; HUMMEL Rolf-Peter,<br />
Radolfzell, DE;<br />
(74) Majlingová Marta, Ing., Bratislava, SK;<br />
(86) PCT/EP2006/060377<br />
(87) WO 2006/092422<br />
(54) (2R,4aR, 10bR)-6-(2,6-dimetoxypyridín-3-yl)-<br />
-9-etoxy-8-metoxy-1,2,3,4,4a, 10b-hexahydro-fenantridín-2-ol,<br />
HCI soľ<br />
(51) C07D 401/00<br />
(11) E 6932<br />
(96) 03772096.8, 29.7.2003<br />
(97) 1537097, 2.12.2009<br />
(24) 2.12.2009<br />
(31) 400356 P, 446451 P<br />
(32) 31.7.2002, 11.2.2003<br />
(33) US, US<br />
(73) E.I. DU PONT DE NEMOURS AND COMPA-<br />
NY, Wilmington, Delaware, US;<br />
(72) ANNIS Gary David, Landenberg, PA, US;<br />
(74) PATENTSERVIS BRATISLAVA, a. s., Bratislava,<br />
SK;<br />
(86) PCT/US2003/023820<br />
(87) WO 2004/011453<br />
(54) Spôsob prípravy 3-halogén-4,5-dihydro-1H-pyrazolov<br />
(51) C07D 401/00, A61K 31/4427, A61P 29/00,<br />
A61P 25/00, A61P 17/00, A61P 15/00,<br />
A61P 13/00, A61P 11/00, A61P 3/00,<br />
C07D 213/00, C07D 403/00<br />
(11) E 6906<br />
(96) 07823371.5, 30.7.2007<br />
(97) 2049525, 30.12.2009<br />
(24) 30.12.2009<br />
(31) 0606988<br />
(32) 31.7.2006<br />
(33) FR<br />
(73) Sanofi-Aventis, Paris, FR;<br />
(72) Dubois Laurent, Paris, FR; Evanno Yannick, Paris,<br />
FR; Malanda André, Paris, FR; Machnik David,<br />
Paris, FR; Gille Catherine, Paris, FR;<br />
(74) Čechvalová Dagmar, Bratislava, SK;<br />
(86) PCT/FR2007/001316<br />
(87) WO 2008/015335<br />
(54) N-(aminoheteroaryl)-1H-indol-2-karboxamidové<br />
deriváty, ich príprava a ich terapeutické použitie<br />
(51) C07D 401/00, A61K 31/4468, A61K 31/4523<br />
(11) E 6869<br />
(96) 05813800.9, 26.10.2005<br />
(97) 1919896, 23.12.2009<br />
(24) 23.12.2009<br />
(31) CH11272005<br />
(32) 12.8.2005<br />
(33) IN<br />
(73) Suven Life Sciences Limited, Hyderabad (Andra<br />
Pradesh), IN;<br />
(72) Ramakrishna Venkata Satya Nirogi, Andhra Pradesh,<br />
IN; Shirsath Vikas Shreekrishna, Andhra<br />
Pradesh, IN; Kambhampati Rama Sastri, Andhra<br />
Pradesh, IN; Vishwakarma Santosh, Andhra Pradesh,<br />
IN; Kandikere Na-garaj Vishwottam, Andhra<br />
Pradesh, IN; Kota Srinivasulu, Andhra Pradesh,<br />
IN; Jasti Venkateswarlu, Andhra Pradesh, IN;<br />
(74) ŽOVICOVÁ & ŽOVIC IP, s. r. o., Bratislava, SK;<br />
(86) PCT/IN2005/000345<br />
(87) WO 2007/020652<br />
(54) Aminoarylsulfónamidové deriváty ako funkčné<br />
5-HT 6 ligandy<br />
(51) C07D 401/00, A61K 31/4523, A61P 37/00,<br />
A61P 11/00<br />
(11) E 6900<br />
(96) 06841477.0, 19.12.2006<br />
(97) 1963307, 25.11.2009<br />
(24) 25.11.2009<br />
(31) 0525897, 0623217<br />
(32) 20.12.2005, 21.11.2006<br />
(33) GB, GB<br />
(73) GLAXO GROUP LIMITED, Greenford, Middlesex,<br />
GB;<br />
(72) HODGSON Simon Teanby, Stevenage Hertfordshire,<br />
GB; PROCOPIOU Panayiotis Alexandrou,<br />
Stevenage Hertfordshire, GB; Vinader Brugarolas<br />
Maria Victoria, Stevenage Hertfordshire, GB;<br />
(74) Majlingová Marta, Ing., Bratislava, SK;<br />
(86) PCT/EP2006/069943<br />
(87) WO 2007/071691<br />
(54) Kyselina 3-(4-{[4-(4-{[3-(3,3-dimetyl-1-piperidinyl)propyl]oxy}fenyl)-1-piperidinyl]karbonyl}-1-naftalenyl)-propánová<br />
alebo propénová<br />
ako antagonista H3 receptora na liečenie zápalových<br />
a/alebo alergických ochorení